首頁 > 市場調查報告書 > 材料

包裝/容器

市場調查報告書

商品編碼

1542553

全球軟膠囊市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Softgel Capsules Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 172 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球軟膠囊市場需求預計將從 2023 年的 88.8 億美元達到近 168.2 億美元的市場規模，2024-2032 年研究期間複合年成長率為 7.36%。

軟膠囊是一種膠囊，通常用於容納液體或粉末藥物，並且比硬明膠膠囊溶解得更快。其主要成分是用山梨醇、甘油或類似多元醇增塑的明膠膜。軟膠囊通常口服。軟膠囊有多種形狀，包括橢圓形、圓形、長方形、管狀和栓劑。軟膠囊在吞嚥困難和服用其他形式藥物的患者（如兒童和老年人）中越來越受歡迎。

市場動態

軟膠囊已經取代了更難以製造的膠囊。因此，市場擴張預計將加速。營養保健品產業的龐大需求預計將推動軟膠囊市場的成長軌跡。軟膠囊已被證明是難溶性藥物的最佳配方，可延長大多數治療化合物的吸收時間。軟膠囊因其優於片劑和其他口服形式的優點而受到歡迎。影響其廣泛接受度的因素包括易於吞嚥、掩味、更好的生物利用度、非反應性、視覺上令人愉悅的外觀和更長的保存期限。所有這些因素都顯著促進了市場成長。注重健康的消費者不斷成長的需求正在推動市場向前發展。此外，製造商正在積極開發創新的空心軟膠囊，這些膠囊更適合製藥、營養保健品和藥妝用途，更方便，進一步促進市場成長。然而，阻礙市場擴張的限制因素是含有水溶性化學物質的軟膠囊的穩定性低以及軟膠囊的價格波動較大。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球軟膠囊市場的每個細分市場進行了包容性評估。軟膠囊產業的成長和趨勢為本研究提供了整體方法。

市場區隔

軟膠囊市場報告的這一部分提供了有關國家和區域層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

按類型

明膠/動物源
非動物性來源

按申請

制酸劑和抗脹氣製劑
抗貧血製劑
抗發炎藥
抗生素和抗菌藥物
咳嗽和感冒製劑
保健品
維生素和膳食補充劑
懷孕

按最終用途

製藥公司
營養保健品公司
藥妝公司
合約製造組織

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲軟膠囊市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。軟膠囊市場的主要參與者包括 Fuji Capsule、Sirio Pharma Co. Ltd.、Captek Softgel International Inc.、Thermo Fisher Scientific Inc.、EyePoint Pharmaceuticals Inc.、Catalent Inc.、EuroCaps、Aenova Group、Lonza Capsules & Health Ingredients 、 ProCaps Laboratories LLC、Soft Gel Technologies Inc。進展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：軟膠囊公司的競爭格局

軟膠囊市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

頂級公司市佔率分析
市場集中度
Fuji Capsule

公司概況
公司收入
產品
最新動態

Sirio Pharma Co. Ltd.

公司概況
公司收入
產品
最新動態

Captek Softgel International Inc.

公司概況
公司收入
產品
最新動態

Thermo Fisher Scientific Inc.

公司概況
公司收入
產品
最新動態

EyePoint Pharmaceuticals Inc.

公司概況
公司收入
產品
最新動態

Catalent Inc.

公司概況
公司收入
產品
最新動態

EuroCaps

公司概況
公司收入
產品
最新動態

Aenova Group

公司概況
公司收入
產品
最新動態

Lonza Capsules & Health Ingredients

公司概況
公司收入
產品
最新動態

ProCaps Laboratories LLC

公司概況
公司收入
產品
最新動態

Soft Gel Technologies Inc

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11216704

The global demand for Softgel Capsules Market is presumed to reach the market size of nearly USD 16.82 Billion by 2032 from USD 8.88 Billion in 2023 with a CAGR of 7.36% under the study period 2024-2032.

A softgel capsule is a type of capsule that is typically used to hold liquid or powdered medicine and dissolves more quickly than a hard gelatin capsule. Its primary constituents are gelatine films that have been plasticized with sorbitol, glycerine, or a similar polyol. Soft gel capsules are usually taken by mouth. Softgel capsules come in various shapes, including oval, round, oblong, tubs, and suppository. Softgel capsules are becoming more popular among patients who have trouble swallowing and consuming medications in other forms, like kids and the elderly.

MARKET DYNAMICS

Softgel capsules have taken the place of more difficult-to-manufacture capsules. As a result, the market's expansion is expected to accelerate. The nutraceutical industry's massive demand is expected to drive the softgel capsule market's growth trajectory. Softgel capsules have been shown to be the best formulation for poorly soluble medications and increase the absorption time of most therapeutic compounds. Softgel capsules have gained popularity due to their advantages over tablets and other oral forms. Factors affecting its widespread acceptability include ease of swallowing, flavour masking, better bioavailability, non-reactivity, visually pleasing appearance, and longer shelf life. All these elements are boosting the market growth significantly. The market is being propelled forward by rising demand from health-conscious consumers. Moreover, manufacturers are actively developing innovative empty softgel capsules that are more adaptable and convenient for pharmaceutical, nutraceutical, and cosmeceutical uses, further augmenting the market growth. However, the constraints impeding market expansion are the low stability of softgel capsules containing water-soluble chemicals and the significant price volatility of softgel capsules.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Softgel Capsules. The growth and trends of Softgel Capsules industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Softgel Capsules market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

Gelatin-Based/Animal-Based
Non-Animal-Based

By Application

Antacid And Anti-Flatulent Preparation
Anti-Anemic Preparations
Anti-Inflammatory Drugs
Antibiotic And Antibacterial Drugs
Cough And Cold Preparations
Health Supplement
Vitamin And Dietary Supplement
Pregnancy

By End-use

Pharmaceutical Companies
Nutraceutical Companies
Cosmeceutical Companies
Contract Manufacturing Organizations

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Softgel Capsules market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Softgel Capsules market include Fuji Capsule, Sirio Pharma Co. Ltd., Captek Softgel International Inc., Thermo Fisher Scientific Inc., EyePoint Pharmaceuticals Inc., Catalent Inc., EuroCaps, Aenova Group, Lonza Capsules & Health Ingredients, ProCaps Laboratories LLC, Soft Gel Technologies Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. SOFTGEL CAPSULES - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-use
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL SOFTGEL CAPSULES MARKET ANALYSIS BY TYPE

5.1. Overview By Type
5.2. Historical and Forecast Data Analysis By Type
5.3. Gelatin-Based/Animal-Based Historic and Forecast Sales By Regions
5.4. Non-Animal-Based Historic and Forecast Sales By Regions

6. GLOBAL SOFTGEL CAPSULES MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Antacid And Anti-Flatulent Preparation Historic and Forecast Sales By Regions
6.4. Anti-Anemic Preparations Historic and Forecast Sales By Regions
6.5. Anti-Inflammatory Drugs Historic and Forecast Sales By Regions
6.6. Antibiotic And Antibacterial Drugs Historic and Forecast Sales By Regions
6.7. Cough And Cold Preparations Historic and Forecast Sales By Regions
6.8. Health Supplement Historic and Forecast Sales By Regions
6.9. Vitamin And Dietary Supplement Historic and Forecast Sales By Regions
6.10. Pregnancy Historic and Forecast Sales By Regions

7. GLOBAL SOFTGEL CAPSULES MARKET ANALYSIS BY END-USE

7.1. Overview By End-use
7.2. Historical and Forecast Data Analysis By End-use
7.3. Pharmaceutical Companies Historic and Forecast Sales By Regions
7.4. Nutraceutical Companies Historic and Forecast Sales By Regions
7.5. Cosmeceutical Companies Historic and Forecast Sales By Regions
7.6. Contract Manufacturing Organizations Historic and Forecast Sales By Regions

8. GLOBAL SOFTGEL CAPSULES MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE SOFTGEL CAPSULES COMPANIES

9.1. Softgel Capsules Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF SOFTGEL CAPSULES INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Fuji Capsule
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Sirio Pharma Co. Ltd.
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Captek Softgel International Inc.
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Thermo Fisher Scientific Inc.
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. EyePoint Pharmaceuticals Inc.
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Catalent Inc.
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. EuroCaps
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Aenova Group
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Lonza Capsules & Health Ingredients
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. ProCaps Laboratories LLC
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments
10.13. Soft Gel Technologies Inc
- 10.13.1 Company Overview
- 10.13.2 Company Revenue
- 10.13.3 Products
- 10.13.4 Recent Developments